lifestyle intervention and vitamin e therapy in obese children with nonalcoholic fatty liver disease
Authors
abstract
patients and methods in the double-blind placebo study, 33 obese children with nafld from 2008 to 2009 were included. lifestyle intervention (balanced calorie diet, 1300-1800 kcal/d and physical activity) was prescribed to all. the patients were concurrently randomized to receive vitamin e 400 mg/d (n = 17)] or placebo (n = 16). results at the end of six months of therapy there was significant change in body mass index, serum aminotransferases, triglycerides, total cholesterol and low density lipoprotein-cholesterol levels in both groups (p <0.001), but the improvement in all these factors was only marginally different between the two groups. alanine aminotransferase decreased to normal levels in 8 of 17 patients (47.05%) in the lifestyle and vitamin e group, and 7 of 16 patients (43.75%) in lifestyle and placebo group. similarly, the improvement in the grade of steatosis on ultrasonography after intervention was the same in both groups. background nonalcoholic fatty liver disease (nafld) is a very common chronic disorder and obesity is thought to be the most common etiology of fatty infiltration of the liver. objectives the objective of this study is to compare the effect of lifestyle intervention alone or in combination with vitamin e therapy in obese pediatric nonalcoholic fatty liver disease (nafld). conclusions lifestyle intervention with diet and physical exercise in obese children with nafld were induced weight loss and was associated with a significant improvement in liver function. vitamin e did not seem to increase the efficacy of lifestyle intervention.
similar resources
Clinical significance of serum alanine aminotransferase and lifestyle intervention in children with nonalcoholic fatty liver disease
PURPOSE This study aimed to investigate the clinical significance of serum alanine aminotransferase (ALT) levels in children with nonalcoholic fatty liver disease (NAFLD) and the effect of lifestyle intervention on NAFLD. METHODS The clinical data of 86 children diagnosed with NAFLD were reviewed retrospectively. Forty-six patients belonged to the elevated ALT group and 40 to the normal ALT g...
full textVitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease
Whether nonalcoholic fatty liver disease (NAFLD) is related to vitamin D and bone health in obese children is unknown. The aim of this study was to evaluate vitamin D status and bone mineral density (BMD) in obese children according to their condition within the NAFLD spectrum. Anthropometric data, laboratory tests, and abdominal ultrasonography were obtained from 94 obese children. The subject...
full textFatty liver disease in obese children in Kashan, Iran
Background: Non-alcoholic fatty liver disease (NAFLD) is increasingly a common disease which is created by the accumulation of fat in the liver. About 20% of adults and 5% of children suffer from this disease. In some studies, half of obese children had fatty liver disease and approximately 90% of the patients with fatty liver were obese. The aim of this study was to evaluate fatty liver diseas...
full textNonalcoholic Fatty Liver Disease Treatment
Nonalcoholic fatty liver disease (NAFLD) is increasing in pediatric age group parallel to the growing prevalence of obesity and overweight all around the world. So changing in life style and interventions on obesogenic environment is cornerstone of NAFLD therapy in obese children. Some experts recommend that children and adolescents be encouraged to follow a low-fat, low-glycemic-index diet t...
full texteffect of vitamin e and metformin on fatty liver disease in obese children- randomized clinical trial.
we evaluated the effect of vitamin e and metformin on fatty liver disease in obese children.this interventional study has been done on 119 children with non-alcoholic fatty liver disease (based on sonography results). patients were divided into four treatment groups; they received metformin 1gr daily (age 12 years), vitamin e 800 u daily and vitamin e 400 u daily. liver sonography was performed...
full textVitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease.
BACKGROUND Comparative trials of ursodeoxycholic acid (UDCA), vitamin E and weight management programs among patients with nonalcoholic fatty liver disease (NAFLD) are lacking. AIM To find an effective single agent or combination of agents for management of NAFLD. METHODS In this retrospective study, consecutive patient with histologically confirmed NAFLD with raised ALT were included. The ...
full textMy Resources
Save resource for easier access later
Journal title:
journal of comprehensive pediatricsجلد ۴، شماره ۱، صفحات ۶۲-۵
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023